Kezar Life Sciences Inc (KZR)

May 05, 2026

Kezar Life Sciences (KZR) Expected to Announce Earnings on Tuesday - MarketBeat

May 05, 2026

May 05, 2026

Kezar Life Sciences, Inc. (NASDAQ:KZR) Given Consensus Recommendation of "Reduce" by Analysts - MarketBeat

May 05, 2026

May 01, 2026

Pharma Co. Investor Sues Over Misleading Aurinia Deal - Law360

May 01, 2026

May 01, 2026

Kezar Life Sciences, Inc. 2025 Executive Compensation, Equity Ownership, and Corporate Governance Overview 171819224546 - Minichart

May 01, 2026

Apr 30, 2026

Kezar Life Sciences (NASDAQ: KZR) details Aurinia tender offer, pay and ownership - Stock Titan

Apr 30, 2026

Apr 29, 2026

Kezar Life Sciences, Inc. (NASDAQ:KZR) Sees Large Decrease in Short Interest - MarketBeat

Apr 29, 2026

Apr 29, 2026

Kezar Life Sciences (KZR) Registration Filing Summary - Quartr

Apr 29, 2026

Apr 27, 2026

Kezar Life Sciences shares surge after Aurinia announces acquisition - MSN

Apr 27, 2026

Apr 27, 2026

Aurinia Pharmaceuticals acquiring Kezar Life Sciences - MSN

Apr 27, 2026

Apr 23, 2026

KZR Kezar Life Sciences Inc. reports far wider Q4 2025 loss than estimates even as shares edge higher.Revenue Diversification - Cổng thông tin điện tử Tỉnh Sơn La

Apr 23, 2026

Apr 20, 2026

Kezar Life (KZR) Stock: Reasonably Valued? (Volatility Increases) 2026-04-20Hot Market Picks - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 20, 2026

Apr 14, 2026

How activist investor Kevin Tang finally landed the Bay Area company that got away from him - The Business Journals

Apr 14, 2026

Apr 14, 2026

Are KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders? - Benzinga

Apr 14, 2026

Apr 14, 2026

M&A Class Action Firm Investigating Multiple Mergers - National Today

Apr 14, 2026

Apr 14, 2026

Aurinia to Acquire Kezar (NASDAQ: KZR) for $6.955 Cash plus CVR - Stock Titan

Apr 14, 2026

Apr 13, 2026

Aurinia to buy Kezar (KZR) for $6.955/Share plus CVR (7.39M shares) - Stock Titan

Apr 13, 2026

Apr 12, 2026

Form 10-KAnnual report [Section 13 and 15(d), not S-K Item 405] - ADVFN

Apr 12, 2026

Apr 12, 2026

Working capital per share of Kezar Life Sciences Inc – FWB:2KZ0 - TradingView

Apr 12, 2026

Apr 12, 2026

KZR Technical Analysis & ETF Price Forecast - Intellectia AI

Apr 12, 2026

Apr 10, 2026

Finance Watch: Replimune Cutting Jobs As FDA Rejects RP1 A Second Time - Citeline News & Insights

Apr 10, 2026

Apr 10, 2026

Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? - GuruFocus

Apr 10, 2026

Apr 10, 2026

Weekly Trades: Will Kezar Life Sciences Inc announce a stock splitInsider Buying & Safe Swing Trade Setups - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Kezar Life Sciences, Inc. (NASDAQ:KZR) Given Average Recommendation of "Reduce" by Brokerages - MarketBeat

Apr 10, 2026

Apr 09, 2026

Published on: 2026-04-10 03:01:28 - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Sectors Review: What are Kezar Life Sciences Incs recent SEC filings showing2026 Short Interest & Reliable Trade Execution Plans - baoquankhu1.vn

Apr 09, 2026

Apr 09, 2026

Aurinia Pharmaceuticals Acquisition Of Kezar Reshapes Autoimmune Growth And Risks - Sahm

Apr 09, 2026

Apr 09, 2026

SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS - Sahm

Apr 09, 2026

Apr 09, 2026

Is Kezar Life (KZR) Stock Breaking Out | KZR Q4 Earnings: Misses Estimates by $0.74Collaborative Trading Signals - Newser

Apr 09, 2026

Apr 08, 2026

SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—KZR, CNTA, AFBI, and APLS - Morningstar

Apr 08, 2026

Apr 08, 2026

Growth Value: Does Kezar Life Sciences Inc meet Warren Buffetts criteria2026 Price Action Summary & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

What limits growth of Kezar Life (KZR) Stock | Price at $7.38, Down 0.14%Stock Ideas - Newser

Apr 08, 2026

Apr 07, 2026

Are KZR, TALK, WBD Obtaining Fair Deals for their Shareholders? - Finviz

Apr 07, 2026

Apr 07, 2026

Pullback Watch: What is the next catalyst for Kezar Life Sciences Inc2026 Fed Impact & Precise Entry and Exit Recommendations - baoquankhu1.vn

Apr 07, 2026

Apr 07, 2026

Shareholder Alert: Ademi LLP investigates whether Kezar - GlobeNewswire

Apr 07, 2026

Apr 06, 2026

Baselake reports 5.3% stake in Kezar Life Sciences (NASDAQ: KZR) - Stock Titan

Apr 06, 2026

Apr 06, 2026

Does Kezar Life Sciences Inc meet Warren Buffetts criteria2026 Volatility Report & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn

Apr 06, 2026

Apr 06, 2026

KZR Q4 2025 Earnings: Kezar Life Sciences Inc. Misses EPS, No RevenueCrowd Sentiment Stocks - Newser

Apr 06, 2026

Apr 05, 2026

Kezar Life Sciences Announces Lease Termination and Executive Separation Agreements in April 2026 - Minichart

Apr 05, 2026

Apr 04, 2026

KZR Technical Analysis & Stock Price Forecast - Intellectia AI

Apr 04, 2026

Apr 04, 2026

Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.96 Per Share Plus Contingent Value Rights in 2026 Merger Deal - Minichart

Apr 04, 2026

Apr 04, 2026

KZR PE Ratio & Valuation, Is KZR Overvalued - Intellectia AI

Apr 04, 2026

Apr 03, 2026

Kezar Life Sciences announces lease termination and executive departures following merger agreement - Investing.com South Africa

Apr 03, 2026